We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rexahn Pharmaceuticals, Inc. | AMEX:RNN | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.24 | 0.00 | 01:00:00 |
Delaware
|
001-34079
|
11-3516358
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
15245 Shady Grove Road
Suite 455
Rockville, MD
|
20850
|
|
(Address of principal executive offices)
|
(Zip Code)
|
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. | Submission of Matters to a Vote of Security Holders. |
Director
|
For
|
Against/Withheld
|
||
Chang H. Ahn
|
61,615,918
|
3,018,958
|
||
Charles Beever
|
61,634,506
|
3,000,370
|
||
Peter Brandt
|
61,652,992
|
2,981,884
|
||
Mark Carthy
|
61,716,865
|
2,918,011
|
||
Kwang Soo Cheong
|
61,679,003
|
2,955,873
|
||
Richard J. Rodgers
|
61,809,275
|
2,825,601
|
||
Peter Suzdak
|
61,759,051
|
2,875,825
|
For
|
Against |
Abstain
|
||
123,320,864
|
4,140,642
|
2,126,452
|
For
|
Against
|
Abstain
|
||
100,326,670
|
28,158,312
|
1,102,974
|
REXAHN PHARMACEUTICALS, INC.
|
||
Date: June 5, 2015
|
||
/s/ Peter Suzdak
|
||
Peter Suzdak
|
||
Chief Executive Officer
|
1 Year Rexahn Pharmaceuticals, Inc. Chart |
1 Month Rexahn Pharmaceuticals, Inc. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions